WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 1632972 PLYMOUTH, MN

Position in ORMP

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$62,024

+$16,128 QoQ

Shares Held

12,895

-4.5% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 84 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. ORMP ranks #120 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$62,024	12,895	-4.5%	Shares	Sole	2026-07-15
2026-03-31	$45,896	13,499	-26.2%	Shares	Sole	2026-04-08
2025-12-31	$52,152	18,299	-2.7%	Shares	Sole	2026-01-08
2025-09-30	$49,629	18,799	0.0%	Shares	Sole	2025-10-29
2025-06-30	$42,297	18,799	+36.2%	Shares	Sole	2025-07-10
2025-03-31	$29,529	13,799	0.0%	Shares	Sole	2025-04-16
2024-12-31	$33,393	13,799	+22.1%	Shares	Sole	2025-03-17
2024-09-30	$27,572	11,300	-0.9%	Shares	Sole	2024-10-24
2024-06-30	$29,298	11,400	0.0%	Shares	Sole	2024-07-16
2024-03-31	$33,288	11,400	-4.2%	Shares	Sole	2024-04-15
2023-12-31	$27,489	11,900	0.0%	Shares	Sole	2024-01-30
2023-09-30	$31,059	11,900	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.